Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.41 USD | +5.71% | +10.00% | +14.57% |
05-02 | NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue | MT |
05-02 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.57% | 1.77B | |
+73.54% | 12.41B | |
-14.92% | 8.23B | |
+4.68% | 6.46B | |
+14.69% | 5.5B | |
-6.15% | 5.33B | |
+42.58% | 5.1B | |
-18.32% | 4.05B | |
-29.67% | 2.54B | |
+10.80% | 1.99B |
- Stock Market
- Equities
- NVCR Stock
- News NovoCure Limited
- Wells Fargo Upgrades NovoCure to Overweight From Equalweight, Adjusts Price Target to $104 From $70